SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.10.10 | Kuros (Kuros Biosciences) hold | Vontobel Research | |
| 27.10.10 | Lonza hold | Vontobel Research | |
| 25.10.10 | Novartis buy | Vontobel Research | |
| 22.10.10 | Novartis kaufen | Independent Research GmbH | |
| 22.10.10 | Novartis buy | Citigroup Corp. | |
| 22.10.10 | Novartis buy | Vontobel Research | |
| 22.10.10 | BB Biotech kaufen | Der Aktionär | |
| 25.10.10 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 22.10.10 | Novartis kaufen | National-Bank AG | |
| 21.10.10 | Novartis hold | Jefferies & Company Inc. | |
| 21.10.10 | Novartis buy | SEB AG | |
| 21.10.10 | Novartis buy | Vontobel Research | |
| 21.10.10 | Novartis buy | Banc of America Securities-Merrill Lynch | |
| 15.10.10 | Novartis buy | Société Générale Group S.A. (SG) | |
| 15.10.10 | Straumann hold | Vontobel Research | |
| 14.10.10 | Sonova halten | Vontobel Research | |
| 13.10.10 | Tecan (N) buy | Vontobel Research | |
| 13.10.10 | Novartis buy | Vontobel Research | |
| 12.10.10 | Novartis buy | Vontobel Research | |
| 13.10.10 | Novartis buy | Citigroup Corp. | |
| 08.10.10 | BB Biotech buy | Close Brothers Seydler Research AG | |
| 08.10.10 | Straumann hold | Vontobel Research | |
| 11.10.10 | Novartis buy | SEB AG | |
| 07.10.10 | Novartis buy | Vontobel Research | |
| 07.10.10 | Novartis buy | UBS AG | |
| 05.10.10 | Novartis buy | Vontobel Research | |
| 04.10.10 | Novartis neutral | UBS AG | |
| 04.10.10 | COLTENE buy | Vontobel Research | |
| 01.10.10 | COLTENE buy | Vontobel Research | |
| 01.10.10 | Novartis buy | Vontobel Research | |
| 30.09.10 | Novartis buy | Vontobel Research | |
| 28.09.10 | Sonova hold | Vontobel Research | |
| 24.09.10 | Novartis buy | Vontobel Research | |
| 23.09.10 | Novartis overweight | Morgan Stanley | |
| 24.09.10 | Novartis buy | Nomura | |
| 23.09.10 | Novartis neutral | Goldman Sachs Group Inc. | |
| 23.09.10 | Novartis kaufen | Independent Research GmbH | |
| 22.09.10 | Novartis buy | Vontobel Research | |
| 20.09.10 | Sonova outperform | Credit Suisse Group | |
| 20.09.10 | Novartis hold | Vontobel Research |